| Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? JF Baker, E Krishnan, L Chen, HR Schumacher The American journal of medicine 118 (8), 816-826, 2005 | 627 | 2005 |
| Gout and the risk of acute myocardial infarction E Krishnan, JF Baker, DE Furst, HR Schumacher Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 613 | 2006 |
| Hyperuricemia and incidence of hypertension among men without metabolic syndrome E Krishnan, CK Kwoh, HR Schumacher, L Kuller Hypertension 49 (2), 298-303, 2007 | 447 | 2007 |
| Long-term cardiovascular mortality among middle-aged men with gout E Krishnan, K Svendsen, JD Neaton, G Grandits, LH Kuller, ... Archives of internal medicine 168 (10), 1104-1110, 2008 | 418 | 2008 |
| Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity G Li, M Yu, WW Lee, M Tsang, E Krishnan, CM Weyand, JJ Goronzy Nature medicine 18 (10), 1518-1524, 2012 | 375 | 2012 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 352 | 2018 |
| Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis EF Chakravarty, L Nelson, E Krishnan Arthritis & rheumatism 54 (3), 899-907, 2006 | 340 | 2006 |
| Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study E Krishnan, BJ Pandya, L Chung, A Hariri, O Dabbous American journal of epidemiology 176 (2), 108-116, 2012 | 328 | 2012 |
| Epidemiology of gout in women: Fifty‐two–year followup of a prospective cohort V Bhole, M De Vera, MM Rahman, E Krishnan, H Choi Arthritis & rheumatism 62 (4), 1069-1076, 2010 | 282 | 2010 |
| A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised … PJ Mease, JS Smolen, F Behrens, P Nash, SL Leage, L Li, H Tahir, ... Annals of the rheumatic diseases 79 (1), 123-131, 2020 | 281 | 2020 |
| Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile HK Choi, MA De Vera, E Krishnan Rheumatology 47 (10), 1567-1570, 2008 | 279 | 2008 |
| Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing JF Fries, D Cella, M Rose, E Krishnan, B Bruce The Journal of rheumatology 36 (9), 2061-2066, 2009 | 260 | 2009 |
| Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout F Perez-Ruiz, L Martínez-Indart, L Carmona, AM Herrero-Beites, JI Pijoan, ... Annals of the rheumatic diseases 73 (1), 177-182, 2014 | 242 | 2014 |
| Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population E Krishnan, T Sokka, A Häkkinen, H Hubert, P Hannonen Arthritis & Rheumatism 50 (3), 953-960, 2004 | 240 | 2004 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 230 | 2019 |
| Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study E Krishnan, BJ Pandya, L Chung, O Dabbous Arthritis research & therapy 13, 1-8, 2011 | 226 | 2011 |
| Factors associated with patients who leave acute-care hospitals against medical advice SA Ibrahim, CK Kwoh, E Krishnan American journal of public health 97 (12), 2204-2208, 2007 | 222 | 2007 |
| Functional disability in rheumatoid arthritis patients compared with a community population in Finland T Sokka, E Krishnan, A Häkkinen, P Hannonen Arthritis & Rheumatism 48 (1), 59-63, 2003 | 216 | 2003 |
| Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory JF Fries, E Krishnan, M Rose, B Lingala, B Bruce Arthritis research & therapy 13, 1-8, 2011 | 187 | 2011 |
| The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration J Fries, M Rose, E Krishnan The Journal of rheumatology 38 (8), 1759-1764, 2011 | 177 | 2011 |
Vidula BholeIndependent Consultant Epidemiology & BiostatisticsVerified email at bioviserglobal.com
